DIA/FDA Oligonucleotide-Based Therapeutics Conference
As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to 1.7 CEUs for the program (primer, short courses, and forum, if applicable). Participants must attend the entire forum, primer, and/or short course, if applicable, in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
|Name||Credit Type||Max Credits||CEU|
|DIA/FDA Oligonucleotide-Based Therapeutics Confere||Credit TypeIACET||Max Credits17.00||CEU1.700|
|DIA/FDA Oligonucleotide-Based Therapeutics Confere||Credit TypeIACET||Max Credits18.50||CEU1.900|
Statement of Credit:
If you would like to receive a statement of credit, you must attend the forum (primer or short course, if applicable), sign in at the registration desk each day, and complete the online credit request process through My Transcript. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on Wednesday, November 13, 2019
To review DIA’s Disclosure and Grievance Policies, visit DIAglobal.org/CE